Precision oncology strategy in cetuximab-resistant ERRFI1-mutant colon cancer: case report of disease progression on afatinib.

导出 OA

翻译打印收藏纠错

作者： Olesya,Kuznetsova ^[1] ; Alexandra,Lebedeva ^[2] ; Alexandra,Kavun ^[1] ; Ekaterina,Belova ^[1] ; Mikhail,Fedyanin ^[1] ; Vladislav,Mileyko ^[3] ; Maxim,Ivanov ^[2] ; Dmitry,Nosov ^[4]

作者单位： OncoAtlas LLC 119049 Moscow, Russia. ^[1] N.N. Blokhin Russian Cancer Research Center 115478 Moscow, Russia. ^[2] Lomonosov Moscow State University 119991 Moscow, Russia. ^[3] State Budgetary Institution of Health Care of The City of Moscow "Moscow Multidisciplinary Clinical Center Kommunarka" of The Department of Health of The City of Moscow 142770 Moscow, Russia. ^[4] Federal State Budgetary Institution "National Medical and Surgical Center Named After N.I. Pirogov" of The Ministry of Health of The Russian Federation 105203 Moscow, Russia. ^[5] Moscow Institute of Physics and Technology 141701 Dolgoprudny, Russia. ^[6] The Central Clinical Hospital of The Administrative Directorate of The President of The Russian Federation 121359 Moscow, Russia. ^[7]

关键词 Colorectal cancer EGFR TKI therapy ERRFI1 mutation molecular tumor board precision medicine

PMID 37854204

发布时间 2023-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交